Researchers continue to excited about Retatrutide , a novel dual agonist showing significant results in early trials for weight loss . It works by modulating both systems: GLP-1 and GIP, that , when https://franceskdrc106824.blogitright.com/41113068/this-new-hope-for-size-loss